The mechanism linking GLP-1 receptor agonists to pancreatitis remains unclear, and causality has not been definitively established, but vigilance for symptoms is warranted
convenient locations Table of Contents: What are tirzepatide injections
It produces a single number that places you somewhere on a scale from underweight to severely obese, and that number has become the primary gatekeeper for GLP-1 medication access
Formulation R1 (3 mg, 7 mg, 14 mg) Weeks 1-4: 3 mg once daily (starting dose, not effective for blood sugar control) Weeks 5-8: 7 mg once daily Week 9 onward: Stay on 7 mg if effective, or increase to 14 mg once daily if more control is needed Formulation R2 (1.5 mg, 4 mg, 9 mg) Weeks 1-4: 1.5 mg once daily Weeks 5-8: 4 mg once daily Week 9 onward: Stay on 4 mg if effective, or increase to 9 mg once daily if more control is needed Who can use it
Reddy's Laboratories and Apotex) are available in Canada through licensed prescribers and pharmacies